|
TMEM50B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.56970000833689E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
4.351000E-01 |
| Stage1-vs-Stage3 |
4.676000E-02 |
| Stage1-vs-Stage4 |
2.016700E-03 |
| Stage2-vs-Stage3 |
2.981700E-02 |
| Stage2-vs-Stage4 |
5.157000E-03 |
| Stage3-vs-Stage4 |
2.526400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.60369999794241E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
3.043200E-01 |
| Caucasian-vs-Asian |
4.528200E-01 |
| AfricanAmerican-vs-Asian |
2.467400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.683400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.241200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.981000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.009000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.042800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.185800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.603000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.537600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.14439568932312E-11 |
| Classical-VS-Follicular |
4.635600E-04 |
| Classical-VS-Other |
5.865400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.38740130495307E-11 |
| Tall-VS-Other |
2.181800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.451380E-01 |
| Follicular-VS-Normal |
1.34959999953388E-07 |
| Other-VS-Normal |
3.38600000004963E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
1.53444999999586E-05 |
|
|
